Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: Evidence for a Th-independent contribution by B cells to virus clearance

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2635-2643

  Mozdzanowska, Krystyna ^a   Maiese, Krista ^a   Gerhard, Walter ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HELPER CELL; HOST RESISTANCE; IMMUNE DEFICIENCY; INFECTION CONTROL; INFLUENZA VIRUS; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD; VIRUS PATHOGENESIS;

EID: 0034161703     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2635     Document Type: Article

References (55)

1. Gubareva, L. V., J. A. McCullers, R. C. Bethel, and R. G. Webster. 1998. Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of Zanamivir on H5N1 infection in mice. J. Infect. Dis. 178:1592.
2. Lu, X., T. M. Tumpey, T. Morken, S. R. Zaki, N. J. Cox, and J. M. Katz. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 72:5903.
3. Riberdy, J. M., K. J. Flynn, J. Stech, R. G. Webster, J. D. Altman, and P. C. Doherty. 1999. Protection against a lethal avian influenza A virus in a mammalian system. J. Virol. 73:1453.
4. Takizawa, T., S. Matsukawa, Y. Higuchi, S. Nakamura, Y. Nakanishi, and R. Fukuda. 1993. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol. 74:2347.
5. Hinshaw, V. S., C. W. Olson, N. Dybdahl-Sissoko, and D. Evans. 1994. Apoptosis: a mechanism of cell-killing by influenza A and influenza B viruses. J. Virol. 68:3667.
6. Singer, S. H., P. Noguchi, and R. L. Kirschstein. 1972. Respiratory disease in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus. Infect. Immun. 5:957.
7. + cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 188:112.
8. Glezen, W. P. 1982. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 4:25.
9. Simonson, L., L. B. Schonberger, D. F. Stroup, N. H. Arden, and N. J. Cox. 1996. The impact of influenza on mortality in the USA. In Options for the Control of Influenza III. L. E. Brown, A. W. Hampson, and R. G. Webster, eds. Elsevier, Amsterdam, p. 26.
10. Fujisawa, H., S. Tsuru, M. Rtaniguchi, Y. Zinnaka, and K. Nomoto. 1987. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection. J. Gen. Virol. 68:425.
11. Reading, P. C., L. S. Morey, E. C. Crouch, and E. M. Anders. 1997. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 71:8204.
12. Garcia-Sastre, A., R. K. Durbin, H. Zheng, P. Palese, R. Gertner, D. E. Levy, and J. E. Durbin. 1998. The role of interferon in influenza virus tissue tropism. J. Virol. 72:8350.
13. Gerhard, W., K. Mozdzanowska, M. Furchner, G. Washko, and K. Maiese. 1997. Role of the B cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159:95.
14. + T-cell mechanism in the control of respiratory virus infections. Immunol Rev. 159:105.
15. + T cells. J. Exp. Med. 174:875.
16. Scherle, P. A., G. Palladino, and W. Gerhard. 1992. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148:212.
17. + T cells. J. Immunol. 144:3980.
18. Bodmer, H., G. Obert, S. Chan, C. Benoist, and D. Mathis. 1993. Environmental modulation of the autonomy of cytotoxic T lymphocytes. Eur. J. Immunol. 23: 1649.
19. Epstein, S. L., C.-Y. Lo, J. A. Misplon, and J. R. Bennink. 1998. Mechanisms of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160:322.
20. + T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239:217.
21. + T cells is inefficient in the absence of B cells. J. Virol. 72:882.
22. Palladino, G., K. Mozdzanowska, G. Washko, and W. Gerhard. 1995. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 69:2075.
23. Mozdzanowska, K., K. Maiese, M. Furchner, and W. Gerhard. 1999. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Virology 254:138.
24. + T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159:5197.
25. Graham, M. B., D. K. Dalton, D. Giltinan, V. L. Braciale, T. A. Stewart, and T. J. Braciale. 1993. Response to influenza infection in mice with a targeted disruption in the interferon γ gene. J. Exp. Med. 178:1725.
26. Cerwenka, A., T. M. Morgan, A. G. Harmsen, and R. W. Dutton. 1999. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189:423.
27. Karupiah, G., J.-H. Chen, S. Mahalingam, C. F. Nathan, and J. D. MacMicking. 1998. Rapid interferon-γ-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188:1541.
28. Von Herrat, M. G., B. Coon, and M. B. A. Oldstone. 1997. Low affinity cytotoxic T-lymphocytes require IFN-γ to clear an acute viral infection. Virology 229:349.
29. Kaegi, D., and H. Hengartner. 1996. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 8:472.
30. Ehl, S., P. Klenerman, P. Aichele, H. Hengartner, and R. M. Zinkernagel. 1997. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 27:3404.
31. Kaegi, D., P. Seiler, J. Pavlovic, B. Ledermann, K, Buerki, R. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25: 3256.
32. + cytotoxic T-cell responses during chronic viral infection. J. Virol 68:8056.
33. Thomsen, A. R., A. Nansen, J. P. Christensen, S. O. Andreasen, and O. Marker. 1998. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J. Immunol. 161:4583.
34. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383.
35. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423.
36. -) variants obtained by mutagenesis of mouse mastocytoma P815. Immunogenetics 26:178.
37. + T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156:465.
38. Liang, S., K. Mozdzanowska, G. Palladino, and W. Gerhard. 1994. Heterosubtypic immunity to influenza type A virus in mice: effector mechanisms and their longevity. J. Immunol. 152:1653.
39. Kavaler, J., A. J. Caton, L. M. Staudt, D. Schwartz, and W. Gerhard. 1990. A set of closely related antibodies dominates the primary antibody response to the antigenic site Cb of the A/PR/8/34 influenza virus hemagglutinin. J. Immunol. 145:2312.
40. Speiser, D. E., D. Kyburz, U. Stubi, H. Hengartner, and R. M. Zinkernagel. 1992. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities: low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. J. Immunol. 149:972.
41. Alexander-Miller, M. A., G. R. Leggatt, and J. A. Berzofsky. 1996. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA 93:4102.
42. Homann, D., A. Tishon, D. P. Berger, W. O. Weigle, M. G. von Herrath, and M. B. A. Oldstone. 1998. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice. J. Virol. 72:9208.
43. b gene. J. Immunol. 155:2955.
44. Hou, S., X. Y. Mo, L. Hyland, and P. C. Doherty. 1995. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins. J. Virol. 69:1429.
45. Thomsen, A. R., J. Johansen, O. Marker, and J. P. Christensen. 1996. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient and B cell-deficient mice. J. Immunol. 157: 3074.
46. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874.
47. Nakamoto, Y., L. O. Guidotti, V. Pasquetto, R. D. Schreiber, and F. V. Chisari. 1997. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J. Immunol. 158:5692.
48. Renegar, K. B., and P. A. Small. 1991. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65:2146.
49. Tamura, S., T. Iwasaki, A. H. Thompson, H. Asanuma, Z. Chen, Y. Suzuki, C. Aizawa, and T. Kurata. 1998. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. J. Gen. Virol. 79:291.
50. Fuchs, E. J., and P. Matzinger. 1992. B cells turn of virgin not not memory T cells. Science 258:1156.
51. + T cells. J. Exp. Med. 188:1877.
52. Schaniel, C., E. Pardali, F. Sallustro, M. Speletas, C. Fuedl, T. Shimizu, T. Seidl, J. Anderson, F. Melchers, A. Rolink, and P. Sideras. 1998. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J. Exp. Med. 188:451.
53. Krzysiek, R., E. A. Lefevre, W. Zou, A. Poussat, J. Bernard, A. Portier, P. Galanaud, and Y. Richard. 1999. Antigen receptor engagement selectively induces macrophage inflammatory protein-1α (MIP-1a) and MIP-1β chemokine production in human B cells. J. Immunol. 162:4455.
54. Szomolanyi-Tsuda, E., and R. M. Welsh. 1996. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J. Exp. Med. 183: 403.
55. Bachmann, M. F., and R. M. Zinkernagel. 1997. Neutralizing antiviral B cell responses. Annu. Rev. 15:235.